China CDC Begins Pilot Survey To Identify New HIV Types
This article was originally published in PharmAsia News
China's Center for Disease Control and Prevention has begun a pilot program aimed at identifying the source of new HIV outbreaks that occur in three provinces of the country through Sept. 30. Under the survey program, the CCDC aims to track the history of the disease in HIV-positive patients and the differences between new outbreaks and previous ones. Health officials hope to use the information to help in creating an AIDS-prevention strategy. (Click here for more
You may also be interested in...
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency and two leading manufacturers.
A proposed rule released last month by the US Department of Health and Human Services is the Trump administration’s “latest attempt to sabotage HHS programs,” wrote Jessica Schubel, a senior policy analyst for the Center on Budget and Policy Priorities. See what the policy expert said about it in her blog post here.
Helped by a hefty financing earlier this year, Bukwang subsidiary Contera Pharma is poised to speed ongoing multinational Phase II trials with its lead asset for Parkinson’s-associated dyskinesia by hiring CNS experts as new top executives, as the Korean firm looks to take it public in ground-breaking move.